|
|
 |
SODIUM CARBONATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM ALGINATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SIMBRINZA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SODIUM BORATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|